AAREYDRUGS.NSAAREYDRUGS.NSNSE
Loading
Year-over-year revenue growth rate
5Y CAGR
-24.6%/yr
Long-term compound
Percentile
P62
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q4 2025 | 14.57% |
| Q3 2025 | -17.66% |
| Q2 2025 | -5.45% |
| Q1 2025 | -19.20% |
| Q4 2024 | 27.24% |
| Q3 2024 | -17.15% |
| Q2 2024 | -39.67% |
| Q1 2024 | 175.06% |
| Q4 2023 | 32.24% |
| Q3 2023 | 13.49% |
| Q2 2023 | -67.79% |
| Q1 2023 | 153.21% |
| Q4 2022 | -18.08% |
| Q3 2022 | -35.01% |
| Q2 2022 | -1.54% |
| Q1 2022 | -15.04% |
| Q4 2021 | 4.17% |
| Q3 2021 | 38.08% |
| Q2 2021 | -45.13% |
| Q1 2021 | 123.14% |
| Q4 2020 | 59.86% |
| Q3 2020 | 97.58% |
| Q2 2020 | -77.22% |
| Q1 2020 | 85.56% |
| Q4 2019 | -6.15% |
| Q3 2019 | -4.00% |
| Q2 2019 | -51.77% |
| Q1 2019 | 75.02% |
| Q4 2018 | 9.49% |
| Q3 2018 | 6.35% |
| Q2 2018 | -42.35% |
| Q1 2018 | 30.46% |
| Q4 2017 | 29.48% |
| Q3 2017 | -6.25% |
| Q2 2017 | -39.99% |
| Q1 2017 | 28.04% |
| Q4 2016 | 16.52% |
| Q3 2016 | -12.90% |
| Q2 2016 | -12.91% |
| Q1 2016 | 71.54% |